Gynecologic Cancer

Increased state spending on social services such as Medicaid correlated with improved 5-year overall survival among Black adults with cancer, according to study results scheduled for presentation at ASCO Annual Meeting.

Individuals who identified as a sexual minority had lower odds of ever undergoing Pap testing compared with heterosexual individuals, according to a study published in Cancer.

A decrease in cervical cancer rates in the United States, most notably among younger women, may be associated with HPV vaccination approval, according to a retrospective, cross-sectional study published in JAMA Network Open.

Researchers reported a sustained increase in uterine carcinoma mortality rates in the U.S. during the past decade, with the highest hysterectomy-corrected rates observed among Black women, according to a study published in JAMA Oncology.

The FDA granted fast track designation to ofranergene obadenovec in combination with paclitaxel for treatment of platinum-resistant ovarian cancer.

Early data from a phase 1 trial showed encouraging clinical activity for an investigational chimeric antigen receptor T-cell therapy alone or in combination with an amplifying mRNA vaccine for patients with solid tumors.

B.J. Rimel, MD, recently named medical director of the Cedars-Sinai Cancer Clinical Trials Office, shared her personal journey to gynecologic oncology and the important role allies can play when facing discrimination.

Arif Kamal, MD, MBA, MHS, chief patient officer at American Cancer Society, spoke with Healio about two national roundtables the society will launch to drive progress against breast cancer and cervical cancer.

Rucaparib monotherapy significantly extended PFS compared with placebo as first-line maintenance treatment for women with ovarian cancer, according to topline data from the randomized phase 3 ATHENA-MONO trial.

Minimally invasive surgery conferred lower survival rates than open surgery among women with cervical cancer, according to randomized phase 3 trial results presented at Society of Gynecologic Oncology 2022 Annual Meeting on Women's Cancer.